Gelonghui August 22?001367.SZ released its semi-annual report for 2023, with operating income of 193 million yuan for the reporting period, down 8.50% from the same period last year; net profit belonging to shareholders of listed companies was 45.8077 million yuan, down 19.45% from the same period last year; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was 44.5433 million yuan, down 13.96% from the same period last year; and basic earnings per share was 0.81 yuan.
海森药业(001367.SZ)：上半年净利降19.45%至4580.77万元
Hyson Pharmaceutical (001367.SZ): Net profit fell 19.45% in the first half of the year to 458.077 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.